The study, sponsored by Rennes University Hospital, investigates cognitive and neural influences on recognition memory in early Alzheimer's Disease (AD). Given the increasing prevalence of AD and the significant unmet medical need for effective diagnostic and therapeutic strategies, this research could inform future drug development and cognitive assessment tools. The findings may enhance understanding of recognition memory deficits in AD-MCI patients, potentially leading to novel therapeutic targets. The competitive landscape includes other cognitive assessment tools and neuroimaging studies, necessitating diligence in evaluating the applicability of results to existing and emerging therapies.